Inventor

CUNDY KENNETH C

US50 patents

⚠️ This page may combine multiple inventors who share the name “CUNDY KENNETH C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CUNDY KENNETH C

XENOPORT INC

Carbidopa prodrugs and derivatives, and compositions and uses thereof

Prodrugs of GABA analogs, compositions and uses thereof

Gemcitabine prodrugs, pharmaceutical compositions and uses thereof

Prodrugs of GABA analogs, compositions and uses thereof

Prodrugs of GABA analogs, compositions and uses thereof

Bile-acid conjugates providing for sustained systemic concentration of drugs

Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs

Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration

Bile-acid conjugates for providing sustained systemic concentrations of drugs

Bile-acid conjugates for providing sustained systemic concentrations of drugs

Orally administered dosage forms of GABA analog prodrugs having reduced toxicity

Gemcitabine prodrugs, pharmaceutical compositions and uses thereof

Levodopa prodrugs, and compositions and uses thereof

Levodopa prodrugs, and compositions and uses thereof

Substrates and screening methods for transport proteins

Levodopa prodrugs, and compositions and uses thereof

Levodopa prodrugs, and compositions and uses thereof

Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use

Levodopa prodrugs, and compositions and uses thereof

Bile-acid conjugates providing for sustained systemic concentration of drugs

Prodrugs of GABA analogs, compositions and uses thereof

Gemcitabine prodrugs, pharmaceutical compositions and uses thereof

Prodrugs of GABA analogs, compositions and uses thereof

Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs

Bile-acid conjugates for providing sustained systemic concentrations of drugs

GABA analog prodrug sustained release oral dosage forms

Methods of using prodrugs of pregabalin

Amino acid conjugates providing for sustained systemic concentrations of GABA analogues

Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration

Amino acid conjugates providing for sustained systemic concentrations of GABA analogues

GABA analog prodrug sustained release oral dosage forms

GILEAD SCIENCES INC

Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability

Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability

Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability

Nucleotide analogs

Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability

Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability

Nucleotide analogs

XENOPORT

Amino acid conjugates providing for sustained systemic concentrations of GABA analogues

Amino acid conjugates providing for sustained systemic concentrations of GABA analogues

COHBAR INC

Therapeutic peptides

Therapeutic peptides

GALLOP MARK A

Amino acid derived prodrugs of propofol, compositions and uses thereof

Prodrugs of GABA analogs, compositions and uses thereof

STERLING DRUG INC

Surface modified drug nanoparticles

STERLING WINTHROP INC

Method to reduce particle size growth during lyophilization

NANOSYSTEMS LLC

Surface modified NSAID nanoparticles

XIANG JIA-NING

Levodopa prodrugs, and compositions and uses thereof

ARBOR PHARMACEUTICALS LLC

Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects

CUNDY KENNETH C

GABA analog prodrug sustained release oral dosage forms